Capricor Therapeutics (CAPR) Receivables - Other (2016 - 2025)
Historic Receivables - Other for Capricor Therapeutics (CAPR) over the last 13 years, with Q3 2025 value amounting to $59167.0.
- Capricor Therapeutics' Receivables - Other fell 8555.78% to $59167.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $59167.0, marking a year-over-year decrease of 8555.78%. This contributed to the annual value of $10.4 million for FY2024, which is 3.38% down from last year.
- Latest data reveals that Capricor Therapeutics reported Receivables - Other of $59167.0 as of Q3 2025, which was down 8555.78% from $59509.0 recorded in Q2 2025.
- In the past 5 years, Capricor Therapeutics' Receivables - Other ranged from a high of $10.4 million in Q4 2023 and a low of $59167.0 during Q3 2025
- Its 5-year average for Receivables - Other is $1.4 million, with a median of $409682.0 in 2024.
- Per our database at Business Quant, Capricor Therapeutics' Receivables - Other skyrocketed by 179415.12% in 2023 and then plummeted by 8555.78% in 2025.
- Over the past 5 years, Capricor Therapeutics' Receivables - Other (Quarter) stood at $391750.0 in 2021, then skyrocketed by 39.78% to $547580.0 in 2022, then surged by 1794.15% to $10.4 million in 2023, then fell by 0.03% to $10.4 million in 2024, then plummeted by 99.43% to $59167.0 in 2025.
- Its Receivables - Other was $59167.0 in Q3 2025, compared to $59509.0 in Q2 2025 and $59834.0 in Q1 2025.